A prospective study to determine effectiveness of inactivated SARS-CoV-2 vaccine (Coronavac) in regard to preventing Covid-19 infection, related hospitalization, admission to ICU and Covid-19-related death
Latest Information Update: 14 Jul 2021
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 14 Jul 2021 New trial record
- 07 Jul 2021 Results published in the New England Journal of Medicine